Compare ANIP & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIP | GABC |
|---|---|---|
| Founded | 2001 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.5B |
| IPO Year | N/A | N/A |
| Metric | ANIP | GABC |
|---|---|---|
| Price | $80.33 | $40.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $102.14 | $45.50 |
| AVG Volume (30 Days) | ★ 417.1K | 130.8K |
| Earning Date | 11-07-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 2.84% |
| EPS Growth | N/A | ★ 3.79 |
| EPS | 1.67 | ★ 2.87 |
| Revenue | ★ $826,880,000.00 | $312,775,000.00 |
| Revenue This Year | $43.41 | $47.67 |
| Revenue Next Year | $9.66 | $6.23 |
| P/E Ratio | $48.00 | ★ $14.23 |
| Revenue Growth | ★ 48.87 | 26.55 |
| 52 Week Low | $52.50 | $32.75 |
| 52 Week High | $99.50 | $45.12 |
| Indicator | ANIP | GABC |
|---|---|---|
| Relative Strength Index (RSI) | 34.84 | 62.79 |
| Support Level | $80.30 | $39.34 |
| Resistance Level | $83.60 | $40.34 |
| Average True Range (ATR) | 2.33 | 0.66 |
| MACD | 0.17 | 0.15 |
| Stochastic Oscillator | 25.86 | 88.84 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.